DR MARKS PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: F82663 | ROMFORD, RM1 2SH
Showing results 101-150 of 399
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Insulin aspart | 139 | 909 | £5.7K | -63.5% ▼ |
| Nitrofurantoin | 138 | 1,700 | £897 | -71.1% ▼ |
| Theophylline | 133 | 3,150 | £1.6K | +59.1% ▲ |
| Tibolone | 133 | 7,588 | £756 | +334.6% ▲ |
| Sildenafil (Erectile Dysfunction) | 133 | 1,812 | £258 | -73.6% ▼ |
| Alginic acid compound preparations | 132 | 85.7K | £1.3K | -77.5% ▼ |
| Loperamide hydrochloride | 131 | 9,296 | £203 | -43.8% ▼ |
| Rosuvastatin calcium | 128 | 4,900 | £146 | -85.7% ▼ |
| Other emollient preparations | 126 | 71.7K | £1.0K | -79.0% ▼ |
| Clonazepam | 125 | 6,208 | £770 | -19.8% ▼ |
| Hydrocortisone | 121 | 4,255 | £742 | -73.0% ▼ |
| Enalapril maleate | 120 | 5,992 | £217 | -33.2% ▼ |
| Nicorandil | 118 | 2,630 | £390 | -18.0% ▼ |
| Fluticasone/umeclidinium/vilanterol | 118 | 124 | £5.2K | -49.7% ▼ |
| Azathioprine | 116 | 2,241 | £59 | +7.0% ▲ |
| Gabapentin | 111 | 11.4K | £620 | -88.9% ▼ |
| Flucloxacillin sodium | 111 | 5,740 | £257 | -75.3% ▼ |
| Ezetimibe | 110 | 1,792 | £329 | -84.5% ▼ |
| 110 | 115 | £688 | -53.4% ▼ | |
| Beclometasone dipropionate | 109 | 126 | £331 | -49.3% ▼ |
| 107 | 1,019 | £627 | -57.1% ▼ | |
| Letrozole | 105 | 3,752 | £327 | -43.8% ▼ |
| Hydralazine hydrochloride | 104 | 2,184 | £131 | +146.5% ▲ |
| 104 | 18.1K | £552 | -78.1% ▼ | |
| Digoxin | 101 | 2,464 | £185 | -73.3% ▼ |
| Pantoprazole | 100 | 2,891 | £144 | -63.6% ▼ |
| Azithromycin | 100 | 2,273 | £761 | -21.1% ▼ |
| Ibuprofen | 99 | 15.2K | £331 | -80.5% ▼ |
| Lactulose | 96 | 51.4K | £485 | -70.8% ▼ |
| Budesonide | 96 | 294 | £4.1K | -82.3% ▼ |
| Carbamazepine | 95 | 15.8K | £904 | -68.0% ▼ |
| Empagliflozin | 95 | 3,780 | £4.7K | -84.8% ▼ |
| Combined ethinylestradiol 30mcg | 92 | 14.0K | £751 | -66.9% ▼ |
| Bezafibrate | 91 | 1,680 | £416 | +68.9% ▲ |
| Powder 1.6 kcal/ml milkshake (0913011) | 91 | 5,450 | £2.7K | +22.0% ▲ |
| Buprenorphine | 90 | 388 | £2.6K | -75.4% ▼ |
| Estradiol | 88 | 4,357 | £1.1K | -89.3% ▼ |
| Etoricoxib | 88 | 1,568 | £383 | +9.2% ▲ |
| Verapamil hydrochloride | 86 | 1,890 | £502 | -5.2% ▼ |
| Codeine phosphate | 86 | 5,988 | £279 | -88.0% ▼ |
| Calcipotriol | 84 | 6,180 | £3.6K | -50.7% ▼ |
| Felodipine | 82 | 1,659 | £265 | -86.2% ▼ |
| Fluticasone furoate/vilanterol | 81 | 102 | £2.6K | -47.7% ▼ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 81 | 2,342 | £252 | -47.0% ▼ |
| Edoxaban | 79 | 2,548 | £4.2K | -88.7% ▼ |
| Hydroxyzine hydrochloride | 79 | 3,640 | £119 | +48.3% ▲ |
| Lymecycline | 78 | 4,802 | £552 | -35.2% ▼ |
| Methyldopa | 77 | 7,368 | £1.7K | +352.1% ▲ |
| Hyoscine butylbromide | 76 | 4,406 | £304 | -67.4% ▼ |
| Carbimazole | 76 | 2,568 | £552 | -32.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.